
KNK-437
CAS No. 218924-25-5
KNK-437( KNK437 )
Catalog No. M13492 CAS No. 218924-25-5
An inhibitor of Heat shock protein (HSP) synthesis that dose-dependently inhibits the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in human colon carcinoma cells.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 47 | In Stock |
![]() ![]() |
10MG | 67 | In Stock |
![]() ![]() |
25MG | 145 | In Stock |
![]() ![]() |
50MG | 263 | In Stock |
![]() ![]() |
100MG | 494 | In Stock |
![]() ![]() |
200MG | 680 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameKNK-437
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn inhibitor of Heat shock protein (HSP) synthesis that dose-dependently inhibits the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in human colon carcinoma cells.
-
DescriptionAn inhibitor of Heat shock protein (HSP) synthesis that dose-dependently inhibits the acquisition of thermotolerance and the induction of various HSPs including HSP105, HSP70, and HSP40 in human colon carcinoma cells; inhibits the acquisition of thermotolerance as developed by sodium arsenite, also inhibited at mRNA levels; shows no antitumor effects and does not increase the thermosensitivity of nontolerant tumors in vivo (up to 200 mg/kg).Colon Cancer Preclinical.
-
In Vitro——
-
In Vivo——
-
SynonymsKNK437
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP105|HSP40|HSP72
-
Research AreaCancer
-
IndicationColon Cancer
Chemical Information
-
CAS Number218924-25-5
-
Formula Weight245.2307
-
Molecular FormulaC13H11NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 34 mg/mL
-
SMILESO=CN1C(/C(CC1)=C\C2=CC=C(OCO3)C3=C2)=O
-
Chemical Name1-Pyrrolidinecarboxaldehyde, 3-(1,3-benzodioxol-5-ylmethylene)-2-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yokota S, et al. Cancer Res. 2000 Jun 1;60(11):2942-8.
2. Koishi M, et al. Clin Cancer Res. 2001 Jan;7(1):215-9.
3. Guo F, et al. Cancer Res. 2005 Nov 15;65(22):10536-44.
molnova catalog



related products
-
PU-H71
PU-H71 is a potent and selective inhibitor of HSP90 with IC50 of 51 nM. Phase 1.
-
17-AAG hydrochloride
A potent Hsp90 inhibitor with IC50 of 5 nM in cell-free assays.
-
ACO1
ACO1 is a potent, selective Grp94 inhibitor with IC50 of 0.44 uM.